Skip to main content

Table 2 Patients’ treatment characteristics and their treatment adherence

From: Treatment non-adherence among methadone maintenance patients and associated factors: a multicenter, cross-sectional study in Vietnam

Treatment characteristics

Number of patients (%)

All patients

Complete adherence (no missing doses)

Non-adherence

1 to 8 missing doses

9 missing doses or higher

Initial drug use age

 < 20

167 (27.8)

82 (49.1)

73 (43.7)

12 (7.2)

 

20 to 29

321 (53.5)

182 (56.7)

121 (37.7)

18 (5.6)

 

30 and higher

112 (18.7)

62 (55.4)

42 (37.5)

8 (7.1)

Duration of drug use (year)

 < 5

115 (19.2)

58 (50.4)

51 (44.3)

6 (5.2)

 

5 to < 10

186 (31.0)

109 (58.6)

66 (35.5)

11 (5.9)

 

10 to < 15

133 (22.2)

68 (51.1)

52 (39.1)

13 (9.8)

 

15 and higher

166 (27.7)

91 (54.8)

67 (40.4)

8 (4.8)

The number of previous treatment

No

124 (20.7)

53 (42.7)

65 (52.4)

6 (4.8)

 

1 to 2

300 (50.0)

176 (58.7)

105 (35.0)

19 (6.3)

 

3 or more

176 (29.3)

97 (55.1)

66 (37.5)

13 (7.4)

Treatment time (year)

 < 3

185 (30.8)

56 (30.3)

121 (65.4)

8 (4.3)

 

3 to 6

198 (33.0)

124 (62.6)

57 (28.8)

17 (8.6)

 

 > 6

217 (36.2)

146 (67.3)

58 (26.7)

13 (6.0)

Daily methadone dose (mg)

 < 60

220 (36.7)

130 (59.1)

75 (34.1)

15 (6.8)

 

60 to 120

298 (49.7)

150 (50.3)

129 (43.3)

19 (6.4)

 

 > 120

82 (13.7)

46 (56.1)

32 (39.0)

4 (4.9)

Comorbidity

No

279 (46.5)

146 (52.3)

118 (42.3)

15 (5.4)

 

Yes

321 (53.5)

180 (56.1)

118 (36.8)

23 (7.2)

Urine opioid tests

Positive

68 (11.3)

23 (33.8)

41 (60.3)

4 (5.9)

 

Negative

532 (88.7)

303 (57.0)

195 (36.7)

34 (6.4)